weight loss drug - Search News

Weight Loss Drug Demand Drives Eli Lilly Sales

Hosted on MSN · 6h

Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected

Eli Lilly expects to provide results from a study in people with obesity and osteoarthritis of the knee in 2025.

Lilly reassures investors that weight-loss drug demand is strong, shares rise

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, banking on the launch of its popular diabetes and weight-loss treatments in new markets.

USA TODAY on MSN · 3d

Here's why researchers think most people stop taking weight loss drugs within a year

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to a new study.

The weight-loss drugs being tested in 2025: will they beat Ozempic?

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

5d

Half of Americans Support Weight-Loss Drugs Like Ozempic for Obesity, Poll

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

23h

Weight loss pill could replace injections, would be transformative for millions

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

13h

Pros and cons of weight-loss jabs

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

1don MSN

Whoopi Goldberg Warns Against AI-Created Ad Using Her Image to Sell Weight-Loss Drug: ‘Do Not Fall for It!’

EGOT winner Whoopi Goldberg railed against an ad that's circulating on social media with a manipulated version of her ...

2d

Investors are growing anxious about Novo Nordisk’s silence since disappointing CagriSema weight loss drug results

Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results